{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:50:27Z","timestamp":1790905827386,"version":"4.1.0"},"reference-count":28,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"Shandong Provincial Hospital Young and Middle aged Innovative Talents Fund Project"},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82102372"],"award-info":[{"award-number":["No. 82102372"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain & Palliative Care Pharmacotherapy"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/15360288.2026.2624502","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T18:12:47Z","timestamp":1771092767000},"page":"311-320","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["The Clinical Application of Suzetrigine"],"prefix":"10.1080","volume":"40","author":[{"given":"Shanhui","family":"Yuan","sequence":"first","affiliation":[{"name":"Stem Cell Clinical Institute, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan City, China"]},{"name":"Department\u2009of\u2009Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan City, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ji","sequence":"additional","affiliation":[{"name":"Stem Cell Clinical Institute, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan City, China"]},{"name":"Department\u2009of\u2009Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan City, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Lu","sequence":"additional","affiliation":[{"name":"Stem Cell Clinical Institute, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan City, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Nantong University Xinglin College","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tang","sequence":"additional","affiliation":[{"name":"Stem Cell Clinical Institute, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan City, China"]},{"name":"Department\u2009of\u2009Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan City, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2012.07.004"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00464"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2019.1663705"},{"issue":"4","key":"e_1_3_2_5_1","first-page":"e23992","article-title":"Reimagining how we treat acute pain: a narrative review","volume":"14","year":"2022","unstructured":"Castroman P, Quiroga O, Mayoral Rojals V, G\u00f3mez M, Moka E, Pergolizzi J Jr, Varrassi G. Reimagining how we treat acute pain: a narrative review. Cureus. 2022;14(4):e23992.","journal-title":"Cureus"},{"issue":"3","key":"e_1_3_2_6_1","first-page":"B5326","article-title":"From acute to chronic postsurgical pain: the significance of the acute pain response","volume":"65","author":"Blichfeldt-Eckhardt MR.","year":"2018","unstructured":"Blichfeldt-Eckhardt MR. From acute to chronic postsurgical pain: the significance of the acute pain response. Dan Med J. 2018;65(3):B5326.","journal-title":"Dan Med J"},{"issue":"1","key":"e_1_3_2_7_1","first-page":"63","article-title":"Pharmacologic therapy for acute pain","volume":"104","author":"Amaechi O","year":"2021","unstructured":"Amaechi O, Huffman MM, Featherstone K. Pharmacologic therapy for acute pain. Am Fam Physician. 2021;104(1):63\u201372.","journal-title":"Am Fam Physician"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-021-00346-w"},{"key":"e_1_3_2_9_1","volume-title":"StatPearls [Internet]","author":"Murphy PB","year":"2024","unstructured":"Murphy PB, Bechmann S, Barrett MJ. Morphine. 2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan."},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25184257"},{"key":"e_1_3_2_11_1","volume-title":"StatPearls [Internet]","author":"Ghlichloo I","year":"2024","unstructured":"Ghlichloo I, Gerriets V. Nonsteroidal anti-inflammatory medications (NSAIDs). 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389201019666181105160744"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2010.08.074"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.04.022"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-024-01295-7"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.124.000944"},{"key":"e_1_3_2_17_1","unstructured":"Vertex V. Announces FDA acceptance of new medication application for suzetrigine for the treatment of moderate-to-severe acute pain [media release]. 2024 Jul 30. https:\/\/news.vrtx.com."},{"key":"e_1_3_2_18_1","unstructured":"US Food & medication Administration. FDA approves novel non-opioid treatment for moderate to severe acute pain [media release]. 2025 Jan 30. https:\/\/www.fda.gov\/."},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209870"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2024.102538"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-024-01265-z"},{"key":"e_1_3_2_22_1","unstructured":"Vertex V. Announces FDA Approval of JOURNAVX\u2122 (suzetrigine) a first-in-class treatment for adults with moderate-to-severe acute pain [media release]. 2025 Jan 30. https:\/\/news.vrtx.com."},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.842032"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00697-0"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2387"},{"key":"e_1_3_2_26_1","unstructured":"Vertex Pharmaceuticals Incorporated. Vertex. Announces positive results from Phase 2 study of VX-548 for the treatment of painful diabetic peripheral neuropathy [media release]. 2023 Dec."},{"key":"e_1_3_2_27_1","unstructured":"Vertex Pharmaceuticals Incorporated. Vertex announces results from Phase 2 study of suzetrigine for the treatment of painful lumbosacral radiculopathy [media release]. 2024 Dec 19."},{"issue":"6","key":"e_1_3_2_28_1","first-page":"1085","article-title":"Suzetrigine, a nonopioid Na V 1.8 inhibitor for treatment of moderate-to-severe acute pain: two Phase 3 randomized clinical trials","volume":"142","year":"2025","unstructured":"Bertoch T, D\u2019Aunno D, McCoun J, Solanki D, Taber L, Urban J, Oswald J, Swisher MW, Tian S, Miao X, et al. Suzetrigine, a nonopioid Na V 1.8 inhibitor for treatment of moderate-to-severe acute pain: two Phase 3 randomized clinical trials. Anesthesiology. 2025;142(6):1085\u201399.","journal-title":"Anesthesiology"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S509144"}],"container-title":["Journal of Pain & Palliative Care Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15360288.2026.2624502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:24:32Z","timestamp":1780341872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15360288.2026.2624502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/15360288.2026.2624502"],"URL":"https:\/\/doi.org\/10.1080\/15360288.2026.2624502","relation":{},"ISSN":["1536-0288","1536-0539"],"issn-type":[{"value":"1536-0288","type":"print"},{"value":"1536-0539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}